Last reviewed · How we verify

NCT05572372

Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality

Completed NA Last updated 11 May 2023
What this trial tests

NA trial testing Acceptance and Commitment Therapy in Compulsive Sexual Behavior in 12 participants. Completed in 31 December 2022.

Timeline
8 January 2022
Primary endpoint
31 July 2022
31 December 2022

Quick facts

Lead sponsorUniversidad Europea de Madrid
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date8 January 2022
Primary completion31 July 2022
Estimated completion31 December 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Europea de Madrid

Who can join

18 and older, any sex, with Compulsive Sexual Behavior or Hypersexuality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of hypersexuality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acceptance and Commitment Therapy

Trials testing the same drug.

Other Universidad Europea de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05572372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing